Opioid-induced constipation can be a frustrating and debilitating side effect of pain management. Fortunately, medical professionals now have access to naloxegol, a medication that specifically targets this issue. In this comprehensive guide, we'll unpack everything you need to know about naloxegol, including its pros and cons, potential side effects, and cost. By the end of this article, you'll have a thorough understanding of how naloxegol works and whether it's the right treatment option for your patients with opioid-induced constipation. So let's dive in!
Naloxegol, also known as Movantik, is a medication used to treat opioid-induced constipation. While it has been proven effective in relieving constipation symptoms caused by opioids, like any other medication, it has its pros and cons.
One of the main advantages of Naloxegol is that it works by blocking the opioid receptors in the gut without affecting pain relief. This means that patients can continue taking their prescribed opioids while also managing their constipation symptoms.
Another advantage is that Naloxegol has a lower risk of abuse than other medications for constipation relief because it does not produce a high or euphoric effect.
On the downside, some common side effects of Naloxegol include abdominal pain, diarrhea, nausea, vomiting and headaches. In rare cases, patients may experience severe allergic reactions which require immediate medical attention.
Another disadvantage is that Naloxegol should be used with caution in patients with liver problems or those taking medications metabolized by CYP3A4 enzymes because it may increase drug levels in the blood leading to potential adverse drug interactions.
Naloxegol is an effective medication for treating opioid-induced constipation, but like any other drug, it comes with potential side effects. While most patients tolerate naloxegol well, some may experience adverse reactions.
One of the most common side effects of Naloxegol is nausea. Patients may feel queasy and uncomfortable after taking the medication. Other gastrointestinal symptoms like diarrhea, vomiting and abdominal pain have also been reported in some cases.
In rare instances, naloxegol can lead to severe allergic reactions such as hives or swelling of the face. In case this happens to a patient, immediate medical attention should be sought.
Some people may also experience headaches while using naloxegol. Dizziness and fatigue are other possible side effects that could affect daily activities.
Naloxegol is a promising medication for managing opioid-induced constipation in patients who are not responding well to other laxatives. It has been shown to be effective and generally safe with few side effects.
As medical professionals, it is important to understand the pros and cons of using naloxegol as part of our treatment strategies. We must monitor our patients closely for any potential side effects and educate them on how to properly use the medication.
Naloxegol offers another option for managing opioid-induced constipation and can greatly improve the quality of life for those suffering from this condition.
1.
EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues
2.
Universal screening approach achieves a comparable detection rate of lung cancer
3.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
4.
The response of bipolar patients to lithium may be predicted by ancestry.
5.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
1.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
2.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
3.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
4.
Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life
5.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Understanding the Role of Screening in Cancer Prevention
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation